- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT03094585
The INFO-II Trial: Nurses Knowledge About and Attitude Towards Clinical Trials (INFO-II)
23 de marzo de 2017 actualizado por: Copenhagen Trial Unit, Center for Clinical Intervention Research
Nurses Knowledge About and Attitude Towards Clinical Trials. A Randomised Trial
The purpose of this study is to examine (a) nurses' knowledge about and attitude towards clinical research, and (b) the effect of written and oral information on nurses' knowledge about and attitude towards clinical research.
Descripción general del estudio
Estado
Terminado
Condiciones
Intervención / Tratamiento
Descripción detallada
A randomised (1:1:1), evaluator-blinded educational trial on written and oral information versus oral information alone versus no information on nurses' knowledge about and attitude towards clinical research in a university hospital in Copenhagen, Denmark.
The investigators planned to randomise 213 nurses (approximately 71 to each intervention group) based on a minimal relevant difference of 1.6 points on the knowledge scale, a standard deviation of 3.1 points, a beta (type II error) risk of 0.20, and an alpha of 0.025.
At entry and two weeks later, the nurses should complete two validated questionnaires, which indicated their knowledge on a 0-17 point scale and their attitude on a 0-156 point scale.
Predictors of the entry knowledge and attitude and changes in knowledge and attitude after interventions were planned to be identified through adjusted ANOVA.
The effects of the active interventions were compared with the control and adjusted for multiple comparisons.
Interventions: Written and oral information: The nurses in this group are offered the written information consisted of a booklet which described basic aspects of clinical research including aim, background, formalities, ethics, informed consent, randomisation, blinding, placebo, drug development, and financial aspects.
The booklet was developed with the assistance of nurses, physicians, psychologists, researchers, and communication experts.
The booklet was adjusted after repeated pilot tests among laymen and employees at our research institution.
The booklet was 12 A4 pages long and took about 15 minutes to read.
In the INFO I trial, the booklet had a significant effect on outpatients' knowledge about and attitude towards clinical research.
The oral information consisted of group sessions which focused on active feedback.
Each session was lead by one of the authors who first went through the topics described in the booklet.
The review of the topics was followed by a plenary discussion.
The sessions lasted 15 to 40 minutes, depending on the interest of the nurses.
Written information: The nurses in this group are offered the written information consisted of the same booklet as above, but without oral information.
No information: The nurses in this group are offered no booklet or oral information.
Tipo de estudio
Intervencionista
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Ubicaciones de estudio
-
-
-
Coepnhagen, Dinamarca, 2200
- Copenhagen Trial Unit, Centre for clinical intervention research
-
Hvidovre, Dinamarca, 2650
- Hvidovre University Hospital
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
18 años y mayores (Adulto, Adulto Mayor)
Acepta Voluntarios Saludables
Sí
Géneros elegibles para el estudio
Todos
Descripción
Inclusion Criteria:
- Graduated nurse
- Signed informed consent
Exclusion Criteria:
- Participant in another trial similar to the present trial
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Otro
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Sin intervención: No information
The nurses in this group are offered no booklet or oral information
|
|
|
Experimental: Written and oral information
The nurses in this group are offered written information which consisted of a booklet describing basic aspects of clinical research including aim, background, formalities, ethics, informed consent, randomisation, blinding, placebo, drug development, and financial aspects.
Furthermore, they are offered oral information which consisted of group sessions focusing on active feedback
|
The written information (booklet) was 12 A4 pages long and took about 15 minutes to read.
The oral information consisted of group sessions which focused on active feedback.
Each session was lead by one of the authors who first went through the topics described in the booklet.
The review of the topics was followed by a plenary discussion.
|
|
Experimental: Written information
The nurses in this group are offered written information which consisted of a booklet describing basic aspects of clinical research including aim, background, formalities, ethics, informed consent, randomisation, blinding, placebo, drug development, and financial aspects.
|
The written information (booklet) was 12 A4 pages long and took about 15 minutes to read.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Knowledge score (questionnaire)
Periodo de tiempo: Two weeks
|
The primary outcome is obtaining satisfactory knowledge score by using a Knowledge questionnaire.
|
Two weeks
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Attitude towards clinical research and randomized clinical trials (questionnaire)
Periodo de tiempo: Two weeks
|
Secondary outcome is the attitude towards clinical research and randomized clinical trials.
This is obtained by using a attitude questionnaire.
|
Two weeks
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Colaboradores
Investigadores
- Investigador principal: Kim Krogsgaard, MD, Copenhagen Trial Unit - Centre for Intervention Research, Denmark
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio
1 de septiembre de 1997
Finalización primaria (Actual)
1 de septiembre de 1997
Fechas de registro del estudio
Enviado por primera vez
25 de agosto de 2016
Primero enviado que cumplió con los criterios de control de calidad
23 de marzo de 2017
Publicado por primera vez (Actual)
29 de marzo de 2017
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
29 de marzo de 2017
Última actualización enviada que cumplió con los criterios de control de calidad
23 de marzo de 2017
Última verificación
1 de marzo de 2017
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- Protocol: 1996-10-31/KK.df
- 1997-DP-31-RKF-5-INFO-II [CTU]
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
NO
Descripción del plan IPD
No plan for data sharing
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .